Literature DB >> 12658774

Study on the mechanism of the annexin II-mediated co-assembly of t-PA and plasminogen.

Xiaohui Zhang1, Huarong Zhou, Guanxin Shen, Zhongping Liu, Yu Hu, Wenning Wei, Shanjun Song.   

Abstract

In order to further investigate the effect of annexin II (Ann-II) on tissue plasminogen activator (t-PA)-dependent plasminogen (PLG) activation and its interactive mechanism, recombinant native Ann-II bound t-PA, PLG and plasmin with high affinity was examined. The flow cytometric assay showed that the ann-II expression rate was higher in the human umbilical vein endothelial cell (HUVEC) (87.65%) than in the HL-60 cells as controls (35.79%). Two irrelevant proteins, bovine serum albumin (BSA) and equine IgG (EIG) had no effect on the production of plasmin. Ann-II-mediated enhancement of t-PA-dependent PLG activation was inhibited by epsilon-aminocaproic acid or by pretreatment of Ann-II with carboxypeptidase B with the inhibitive rate being 77.8% and 77.0%, respectively. It was revealed that the effect of Ann-II on PLG activation was specific for t-PA. Urokinase didn't bind to Ann-II, demonstrating the role of receptor-related lysine residues on activation of PLG, showing that the Ann-II-PLG interaction was dependent upon carboxyl-terminal lysine residues. These findings suggest that annexin II-mediated co-assembly of t-PA and PLG may promote plasmin generation and play a key role in modulating fibrinolysis on the endothelial surface.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12658774     DOI: 10.1007/BF02904779

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

Review 1.  Annexin II: a mediator of the plasmin/plasminogen activator system.

Authors:  K A Hajjar; S Krishnan
Journal:  Trends Cardiovasc Med       Date:  1999-07       Impact factor: 6.677

Review 2.  Receptors for plasminogen and t-PA: an update.

Authors:  A Redlitz; E F Plow
Journal:  Baillieres Clin Haematol       Date:  1995-06

Review 3.  Annexin II: a novel mediator of cell surface plasmin generation.

Authors:  K A Hajjar; J S Menell
Journal:  Ann N Y Acad Sci       Date:  1997-04-15       Impact factor: 5.691

4.  Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer.

Authors:  K S Choi; S L Fitzpatrick; N R Filipenko; D K Fogg; G Kassam; A M Magliocco; D M Waisman
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

Review 5.  The annexinopathies: a new category of diseases.

Authors:  J H Rand
Journal:  Biochim Biophys Acta       Date:  2000-12-20

6.  Annexin II and bleeding in acute promyelocytic leukemia.

Authors:  J S Menell; G M Cesarman; A T Jacovina; M A McLaughlin; E A Lev; K A Hajjar
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

7.  Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine.

Authors:  K A Hajjar; L Mauri; A T Jacovina; F Zhong; U A Mirza; J C Padovan; B T Chait
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

8.  Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2.

Authors:  K A Hajjar; C A Guevara; E Lev; K Dowling; J Chacko
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

9.  An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.

Authors:  G M Cesarman; C A Guevara; K A Hajjar
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

10.  Annexin II contains two types of Ca(2+)-binding sites.

Authors:  M Jost; K Weber; V Gerke
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.